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"rh¢ binding of the non.sele~liv~ =nu=earinic antal~onist [H-llquinuelidin~l ben~ilate (QNB) to rat parotid membranes was ¢har~¢terixed. tinder equi- 
librium condhions, VH]QNB hound to ~ homogeno~ls population or mas~rinie re<cptors (/ca. I1~¢ 19 pM: #~,, 572~42 fmol/mtr n~embrane 
pr~tetn, n~,, 12), The addition of G protein aetivatoes A]F~ nr gtmnosine.~,'-O,(3-thiotriphos;phate) (GTPTS)+ MI~" increased the K,, by ??'.I:?~ 
0m ~ 4, P < 0,05) and 1t3 ± 27,~ (n -~ 7. P < O,05}, respectively, without ;t chanlle in the B~,., or homogeneity of the binding silo~, GTPy$ added without 
exogenous Mg:" did not affect [~ HIQNB binding. Thus, optimal ON B binding requires a mu~arinic receptor/G pr0t¢in interaction, 
Antal/onist; Receptor; G protein: Parotid; AIF'.d GTPTS 
1. INTRODUCTION 
Previous studies have shown that the affinity of 
receptors for agonists is influenced by G proteins [1-4]. 
Conversely, antagonists are commonly believed to be 
unaffected by any G protein mediated changes in recep- 
tor' characteristics [5], Recently, we reported that the 
non-selective muscarinic receptor antagonist (NSMRA) 
atropine could affect #.adrenoreceptor-induced signal 
transduction events related to Ca ~* mobilization in m- 
tact rat parotid acinar cells via a mechanism which 
utilized the muscarinic receptor but which occurred at a 
step distal to ligand binding to the receptor [6]. This led 
to an hypothesis that atropine binding to the muscarinic 
receptor involves a G protein interaction. In the present 
study we have examined the equilibrium binding of  the 
NSMRA QNB to parotid muscarinic receptors, under 
conditions that are known to influence receptor/G pro- 
tein interactions. 
2. MATERIALS AND METHODS 
Parotid menabranes were prepared from male rats as described [7]. 
A1 [3H]QNB binding studies were carried out (37°C, 90 mix) in a 
total volume of 1 ml 50 mM Tris, pH 7.4, containing 50.ag membrane 
protein. Equilibrium binding was achieved within 60 mix in both con- 
trol and experimental conditions (Fig. 1). Incubations were stopped 
by rapid filtration (45 am Millipore filters). Values for all data points 
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were determined in triplicate for each experiment, Speclfie blndinltl 
was calculated as the difference be:wee, n total binding and bindinR 
observed in the i~resence of I 0/tM atropine and was ~ 70010 or total 
bindint~ at QNB concentrations near the K~. Where Indicated P values 
were determined by Student's t.test, [JHIQNB (33 Ci/mmol) was ob- 
tained from New England Nuclear and nucleotides were from Sigma 
Chemical Co. All other eagents were of the hishest available com. 
mercial grade. 
3 RESULTS AND DISCUSSION 
The NSMRA [~HIQNB showed high affinity, 
saturable binding to an apparently homogeneous 
population of muscarinic receptors in rat parotid gland 
membranes. Scatchard-Rosenthal nalysis (Fig. 2, 
open circles), demonstrates binding with an average 
Bmax of 572_+42 fmol/mg membrane protein 
(mean __. SEM; n= 12) and a K,t of  118± 19 pM. These 
data are in good agreement with previously published 
results [8-10]. 
The ability of  guanine nucleotides to decrease the 
stability of the agonist/receptor/G protein complex is 
well known [3,5]. However, the effects of guanine 
nucleotides on the antagonist/receptor/G protein com- 
plex have not been extensively studied, and are  not 
necessarily predictable [11-15]. We found that the addi- 
tion of  100/zM GDP, GTP, inosine 5'-triphosphate, 
guanosine 5' -O-(2-thiodiphosphate), GTP,yS or 
5'-guanylyl imidodiphosphate in he absence of Mg~ +, 
had no significant effect on QNB binding to rat parotid 
membranes either when added simultaneously with the 
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Volgme 2#~, number 2 FE I~ I.ETTI~R~ M~y 1991 
=00 
|SO 
tOO 
~0 
0 20 ~0 160 eO 80 I00 ~0 ~o 
Time in minute~= 
Fi~, I. "rime ~;ourse of ~peel fi,e I'H IQNI~ blntlinL= to rat parettd mere. 
branes. Open t:|r¢les represent the ~pe~;ifl¢ btndln~ of I~HIQNB to 
~:ontrol rat parotld membr=mes (averai=e or ] experiment~, earth per. 
formed in triplicate with different membrane preparalion~) at th~ 
time points Indicated, TI~e solid circles represent he specific: bindinil 
of {~FIIQNPi in the presence of I0 mM NiIF and IO#M AICIt deter. 
mined from experlmenls parallel to those ~hown as control eondi. 
lions, The insel =thow.~ the same experimental da~. expressed ;ts a 
pereental~e of the maximal bi~tdinll in control (e) and esperim¢otal 
(m) conditions, respectively. 
[~H]QNB, or if pre-incubated with the membranes for 
30 rain prior to the addition of  the radioligand, 
However, a significant change in "~[HIQNB binding 
was observed in the presence of Mg =÷ + GTP.yS 
(Fig, 2, triangles), The affinity of  the muscarinic recep- 
tor for the ligand was reduced (K,t increased by 
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Fig, 2. Effect of G.protein activators on specific [3H]QNB binding to 
rat parotid membranes, These Scotehard-Rosenthal plots are from 
representative experiments. The open circles represent the specific 
binding of [aH]QNB under control conditions, (Kd 83 pM, B.,~ 518 
fmol/mg membrane protein), The solid circles represent the specific 
binding of [aHIQNB in the presence of I0 mM NaF and 10aM AICIa 
from the same xperiment as shown for the control (K~ 156 pM, Bmax 
522 fmol/mg membrane protein), The triangles are the average of 2 
experiments with one membrane preparation i which the membranes 
were pretreated with MgSO4 and GTP,yS before the addition of QNB 
(Kd 170 pM, Bnmx 522 fmol/mg membrane protein). For simplicity the 
control QNB binding isotherm from these xperiments is not in- 
dicated as it is comparable to the control results hown These results 
are representative of 4 experiments with 3 separate membrane 
preparations for AIF4- and 7 experiments with 4 separate membrane 
preparations for MgSO4 and GTP,,/S, 
I~ft'e¢l, or M~ :~ ~lld AIF~ ¢~n I'HIQNB hi. in# oa p~r~ttd m,~m. 
br~tt~¢~ 
Add, tlh~n ~v~ M~sim~l ~NI I  l}ound 
¢~n|rol fabric ~ 10o 
10 mM MtI$O~ 
tO mM N:~F plu~ 
IO #M AICh  
I0 m,M N¢ICI plu,t 
10#M AICh 
l0 mM MtISO,~ plu~ 
I0 InN1 NaF plus 
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I]indin~ ,~ltJdies were perrormed ~s tle~¢ribed in th~ text, The mlmbc~r 
of es periment~ for e=teh ~:onditl~n i~ indie~tetl in par~.nthes¢~ At lea~t 
2 different membrane prepanttion,~ were utilized, Each w=~s done in 
lripli~:ale at 100 pM ONB, Data were i~tted for s 8niflea ~¢e by Slu. 
den;',~/.leSt, 
Indicnle~ a result significantly different from ihe control, 
(P<O.00~}, and t~ indic=ties a result sii;nifieantly different other 
resulls so marked (P<: 0,0.~), Under lhe~e control conditions mttx- 
im:tl QNB bindin~ was 215 ± "1 fmol/m~ protein. 
9~1 ~ 4,04 t;l)" 
J&'; ~ 1,32 (3) *-r' 
83 ".t: 27°7o, n = 7, P<0,05)  without a significant change 
in the B.,ax (109 :t: 14070 of control), It is well known that 
Mg z* is needed for optimal activation of  G proteins, 
and facilitates the release of G proteins from tile recep- 
tor [16-19]. Indeed, in the presence of  Mg =* alone, (10 
mM MgSOa), [3H]QNB binding to parotid membranes 
was slightly, but significantly reduced (Table I), These 
data suggest that, in the absence of  Mg 2., the rat 
parotid muscarinic receptor/antagonist complex retains 
a 'relatively' high affinity for G proteins regardless of  
the guanine nucleotide present. Conversely, in the 
presence of  10 mM Mg 2+, GTP,yS can apparently ac- 
tivate the G protein and decrease the receptor's affinity 
for the antagonist. 
We next evaluated the effect o f  AIF4- (10 mM NaF 
and 10 #M AICI~), on [3H]QNB binding to rat parotid 
membranes. A IF4- ,  by interacting with bound GDP on 
Go subunits, is believed to activate G proteins and, 
thus, decrease the association of  G proteins with cell 
surface receptors [20-22]. At a [3H]QNB concentration 
near the Ka, AIF4-  markedly decreased specific 
equilibrium ligand binding to parotid membranes 
( - 35070, Table I) without affecting non-specific binding 
(not shown). The time to reach equilibrium binding was 
unchanged by the addition of  A1F4- (Fig, 1) This in- 
hibitory effect was  specific for the fluoride complex, 
(Table I). The reduction in [3H]QNB binding was 
dependent on the concentration of  NaF present 
( IC5o-3.5  mM NaF, Fig. 3). The effect of A IF4-  on 
QNB binding was similar to the effect of Mg 2÷ and 
GTPTS (Fig. 2), In the presence of 10 mM NaF/IO/zM 
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AICia, the affinity of the antagonist for the receptor 
was significantly reduced, its R',s increased by 77 :t:707o 
(n =4, P<0,05) (•g, 2, solid circles). No significant 
change was observed either in the maximum number of 
binding sites (95 ±7% of control), or in tt~e apparent 
homogeneity of these sites. Interestingly. Mg 2. also 
significantly enhanced the ability of AIF4" to inhibit 
[aH]QNB binding (Table I). These aggregate results 
suggest that in parotid membranes the binding of QNB 
is reduced when G protein/receptor interactions 
decrease. 
It has been widely demonstrated that GTP or non. 
hydrolyzable GTP analogues (such as GTP.yS) change 
the affinity of a receptor for an agonist [1-7]. For this 
to occur, GTP~S must  interact with the G protein, 
leading to its activation and dissociation from the 
receptor. Our data demonstrate hat GTP~,S alone can- 
not alter the affinity of the parotid muscarmic receptor 
for an antagonist. This indicates either that (it GTP~S 
by itself, is unable to activate G proteins associated with 
the antagonist/receptor complex or (ii) antagonist 
binding to the receptor does not require an interaction 
with the G protein and, thus, GTP,yS activation is ir- 
relevant. By e~perimental manipulation (e.g. inclusion 
of Mg 2+ with GTP3,S in reaction mixtures) it was possi- 
ble to induce G protein dissociation from the receptor 
with a subsequent decrease in ligand binding, thus sup- 
porting the first supposition. Furthermore, this can be 
mimicked, without addition of GTP3,S, by utilizing a 
receptor-independent tool for G protein activation, 
A1F4-. Indeed, we have shown that under 4 incubation 
conditions which promote receptor/G protein dissocia- 
tion (Mg 2~ alone; GTP,,/S plus Mg2+; A1F4- alone; and 
A1F,,- plus Mg z÷) the binding of QNB to muscarinic 
receptors is significantly reduced. While this affinity 
change ( -2  fold) is much slnaller than the change in 
agonist affinity ( -  5-100 fold) which has been observed 
as a consequence of G protein/receptor dissociation, it 
nonetheless demonstrates soiree unexpected similarities 
between stimulatory and inhibitory ligand/muscarinic 
receptor/G protein interactions in rat parotid mem- 
branes. 
These similarities are illustrated in Fig. 4. Agonist 
binding to receptors on whole ceils is measured almost 
entirely as low affinity binding (left panel) because the 
agonist very rapidly promotes O protein binding and G 
protein activation. This activation, in turn, very rapidly 
decreases the association of the G protein with the 
receptor and the affinity of tile receptor for the agonist 
(i.e. resulting in the low affinity state of the receptor for 
the agonist). In membranes where endogenous guanine 
nucleotides are limited or absent, the agonist cannot ac- 
tivate the G protein and the agonist remains bound with 
high affinity to its receptor [23-26]. 
On the other hand, antagonists are known to bind 
with high affinity to receptors in whole cells and in 
membranes [23-26]. The model shown in Fig. 4, right 
panel, can explain this phenomenon by virtue of the un- 
changed affinity of the receptor for the antagonist 
regardless of the guanine nucleotide bound to the G 
protein when the G protein stays bound to the receptor. 
The data, herein, demonstrate a lower affinity binding 
of the antagonist to the receptor when the G proteins 
have been dissociated from the receptor either using 
AiF4= or Mg :÷ and GTP3,S, Thus, we suggest that for 
highest affinity [3H]QNB binding to muscat|nit recep- 
tors in rat parotid membranes, an interaction between 
the muscarinic receptor and G protein is required. 
291 
Volume 2~2, number 2 FEB$ LI~TTFI~S M~y 1991 
The G protein.promoted, hi=h af f in i ty  muscarinic 
antai|onist!recep|or bindin8 character ist ics descr ibed 
by us for parotid membranes are clearly not common to 
every cell, or receptor type. For e~ample, in many 
studies, no evidence for  such anta~onis¢/r¢ceptor/G 
protein Interactions has been found. The factors which 
determine the specific nature o f  this interaction are not 
presently understood, 
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